Deborah Rasin - 13 Dec 2021 Form 4 Insider Report for Hill-Rom Holdings, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Dec 2021, 19:40:35 UTC
Prior SEC filing
16 Nov 2021
Next SEC filing
22 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ari D. Mintzer as Attorney-in-Fact for Deborah M. Rasin

Key filing fact

Deborah Rasin filed Form 4 for Hill-Rom Holdings, Inc. on 15 Dec 2021.

Key facts

  • This page summarizes Deborah Rasin's Form 4 filing for Hill-Rom Holdings, Inc..
  • 10 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 15 Dec 2021, 19:40.

Change

  • Previous filing in this sequence was filed on 16 Nov 2021.
  • Current net transaction value: -$2,569,281.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HRC transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-26,527
Change %
-100%
Price
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRC transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$703,596
Shares
-9,039
Change %
-100%
Price
$77.84
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,039
Exercise price
$78.16
Footnotes
F2
HRC transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$506,150
Shares
-8,573
Change %
-100%
Price
$59.04
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,573
Exercise price
$96.96
Footnotes
F3
HRC transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$568,779
Shares
-10,754
Change %
-100%
Price
$52.89
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,754
Exercise price
$103.11
Footnotes
F4
HRC transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$790,756
Shares
-12,783
Change %
-100%
Price
$61.86
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,783
Exercise price
$94.14
Footnotes
F5
HRC transaction Derivative

Performance-Based Restricted Stock Units (11/06/2019)

Disposed to Issuer

Transaction value
Shares
-5,173
Change %
-100%
Price
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,173
Exercise price
Footnotes
F6, F7
HRC transaction Derivative

Performance-Based Restricted Stock Units (11/11/2020)

Disposed to Issuer

Transaction value
Shares
-6,480
Change %
-100%
Price
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,480
Exercise price
Footnotes
F6, F8
HRC transaction Derivative

Restricted Stock Units (11/06/2019)

Disposed to Issuer

Transaction value
Shares
-870
Change %
-100%
Price
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
870
Exercise price
Footnotes
F9, F10
HRC transaction Derivative

Restricted Stock Units (11/11/2020)

Disposed to Issuer

Transaction value
Shares
-2,157
Change %
-100%
Price
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,157
Exercise price
Footnotes
F9, F11
HRC transaction Derivative

Restricted Stock Units (11/10/2021)

Disposed to Issuer

Transaction value
Shares
-8,878
Change %
-100%
Price
Shares after
0
Date
13 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,878
Exercise price
Footnotes
F9, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Deborah Rasin is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 12 footnotes

Footnote F1

Disposed of pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter (the "Merger Agreement") in exchange for a cash payment of $156.00 per share of common stock.

Footnote F2

Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 8, 2018, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.

Footnote F3

Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 7, 2019, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.

Footnote F4

Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 6, 2020, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.

Footnote F5

Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 11, 2021, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.

Footnote F6

Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.

Footnote F7

Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level.

Footnote F8

Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level.

Footnote F9

Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.

Footnote F10

Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.

Footnote F11

Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.

Footnote F12

Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .